Cetuximab in combination with irinotecan/5-fluorouracil/folinic acid (FOLFIRI) in the initial treatment of metastatic colorectal cancer: a multicentre two-part phase I/II study

被引：0
|
作者：
Jean-Luc Raoul
Jean-Luc Van Laethem
Marc Peeters
Catherine Brezault
Fares Husseini
Laurent Cals
Johannes Nippgen
Anja-Helena Loos
Philippe Rougier
机构：
[1] Digestive Oncology Department,Gastroenterology Department
[2] Centre E Marquis,undefined
[3] Hôpital Universitaire Erasme,undefined
[4] Ghent University Hospital,undefined
[5] Hôpital Cochin,undefined
[6] Hôpital Pasteur,undefined
[7] Oncology Service,undefined
[8] Hôpital Font Pré,undefined
[9] BP1412,undefined
[10] Merck KGaA,undefined
[11] Hôpital Ambroise Paré,undefined
来源：
BMC Cancer | / 9卷
关键词：
Epidermal Growth Factor Receptor; Irinotecan; Cetuximab; Folinic Acid; Epidermal Growth Factor Receptor Expression;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] A phase I/II study of arfolitixorin and 5-fluorouracil in combination with oxaliplatin (plus or minus bevacizumab) or irinotecan in metastatic colorectal cancer
    Carlsson, G.
    Koumarianou, A.
    Guren, T. K.
    Haux, J.
    Katsaounis, P.
    Kentepozidis, N.
    Pfeiffer, P.
    Braendengen, M.
    Mavroudis, D.
    Taffin, H.
    Skintemo, L.
    Tell, R.
    Papadimitriou, C.
    ESMO OPEN, 2022, 7 (05)
  • [22] Biweekly oxaliplatin plus irinotecan and folinic acid-modulated 5-fluorouracil: a phase II study in pretreated patients with metastatic colorectal cancer
    Comella, Pasquale
    Massidda, Bruno
    Palmeri, Sergio
    Putzu, Carlo
    De Rosa, Vincenzo
    Izzo, Francesco
    Fiore, Francesco
    Casaretti, Rossana
    Sandomenico, Claudia
    ANTI-CANCER DRUGS, 2006, 17 (08) : 985 - 992
  • [23] A phase II study of irinotecan plus chronomodulated oxaliplatin, 5-fluorouracil and folinic acid in advanced colorectal cancer patients
    C Garufi
    E Bria
    B Vanni
    A M R Zappalà
    I Sperduti
    E Terzoli
    British Journal of Cancer, 2003, 89 : 1870 - 1875
  • [24] Irinotecan and chronomodulated infusion of 5-fluorouracil and folinic acid in the treatment of patients with advanced colorectal carcinoma -: A phase I study
    Garufi, G
    Dogliotti, L
    D'Attino, RM
    Tampellini, M
    Aschelter, AM
    Pugliese, P
    Perrone, M
    Nisticó, C
    Comis, S
    Terzoli, E
    CANCER, 2001, 91 (04) : 712 - 720
  • [25] A phase II study of irinotecan plus chronomodulated oxaliplatin, 5-fluorouracil and folinic acid in advanced colorectal cancer patients
    Garufi, C
    Bria, E
    Vanni, B
    Zappalà, AMR
    Sperduti, I
    Terzoli, E
    BRITISH JOURNAL OF CANCER, 2003, 89 (10) : 1870 - 1875
  • [26] 5-fluorouracil plus calcium leucovorin and irinotecan in the treatment of metastatic colorectal cancer: Phase II study
    Salek, T.
    Mego, M.
    Mardiak, J.
    Porsok, S.
    Hlavata, Z.
    Dolinsky, J.
    Palacka, P.
    ANNALS OF ONCOLOGY, 2008, 19 : 86 - 86
  • [27] Phase II study of infusional 5-fluorouracil, leucovorin, and irinotecan (FOLFIRI) plus bevacizumab as first-line treatment for metastatic colorectal cancer
    Kopetz, S.
    Glover, K. Y.
    Eng, C.
    Wolff, R. A.
    Chang, D. Z.
    Adinin, R. B.
    Morris, J.
    Abbruzzese, J. L.
    Hoff, P. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [28] 5-FLUOROURACIL AND FOLINIC ACID IN THE TREATMENT OF METASTATIC COLORECTAL-CANCER - REPLY
    BUDD, GT
    BUKOWSKI, RM
    MCCRACKEN, JD
    MACDONALD, JS
    JOURNAL OF CLINICAL ONCOLOGY, 1987, 5 (09) : 1492 - 1493
  • [29] Phase II study of irinotecan, leucovorin, 5-fluorouracil and tegafur/uracil for metastatic colorectal cancer
    Kono, T
    Ebisawa, Y
    Tomita, I
    Chisato, N
    Kamiya, K
    Asama, T
    Ayabe, T
    Ashida, T
    Kohgo, Y
    Kasai, S
    JOURNAL OF CHEMOTHERAPY, 2005, 17 (02) : 224 - 227
  • [30] Phase I study of gefitinib, irinotecan, 5-fluorouracil and leucovorin in patients with metastatic colorectal cancer
    Jeffrey A. Meyerhardt
    Jeffrey W. Clark
    Jeffrey G. Supko
    Joseph P. Eder
    Shuji Ogino
    Clinton F. Stewart
    Ferdinando D’Amato
    Janet Dancey
    Peter C. Enzinger
    Andrew X. Zhu
    David P. Ryan
    Craig C. Earle
    Robert J. Mayer
    Ann Michelini
    Kate Kinsella
    Charles S. Fuchs
    Cancer Chemotherapy and Pharmacology, 2007, 60 : 661 - 670
12345